Petros Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 19.48
| PTPI Stock | USD 0.34 0.06 21.43% |
Petros |
Petros Pharmaceuticals Target Price Odds to finish over 19.48
The tendency of Petros Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 19.48 or more in 90 days |
| 0.34 | 90 days | 19.48 | close to zero percent |
Based on a normal probability distribution, the odds of Petros Pharmaceuticals to move over $ 19.48 or more in 90 days from now is close to zero percent (This Petros Pharmaceuticals probability density function shows the probability of Petros Stock to fall within a particular range of prices over 90 days) . Probability of Petros Pharmaceuticals price to stay between its current price of $ 0.34 and $ 19.48 at the end of the 90-day period is about 40.29 .
Given the investment horizon of 90 days Petros Pharmaceuticals has a beta of -0.37 indicating as returns on the benchmark increase, returns on holding Petros Pharmaceuticals are expected to decrease at a much lower rate. During a bear market, however, Petros Pharmaceuticals is likely to outperform the market. Additionally Petros Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Petros Pharmaceuticals Price Density |
| Price |
Predictive Modules for Petros Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Petros Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Petros Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Petros Pharmaceuticals is not an exception. The market had few large corrections towards the Petros Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Petros Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Petros Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.05 | |
β | Beta against Dow Jones | -0.37 | |
σ | Overall volatility | 0.04 | |
Ir | Information ratio | -0.03 |
Petros Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Petros Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Petros Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Petros Pharmaceuticals had very high historical volatility over the last 90 days | |
| Petros Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Petros Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 5.82 M. Net Loss for the year was (8.16 M) with profit before overhead, payroll, taxes, and interest of 6.21 M. | |
| Petros Pharmaceuticals currently holds about 13.3 M in cash with (7.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.64, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from MacroaxisInsider: Acquisition by Gesek Andrew of tradable shares of Petros Pharmaceuticals at 3.99 subject to Rule 16b-3 |
Petros Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Petros Stock often depends not only on the future outlook of the current and potential Petros Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Petros Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.2 M | |
| Cash And Short Term Investments | 13.3 M |
Petros Pharmaceuticals Technical Analysis
Petros Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Petros Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Petros Pharmaceuticals. In general, you should focus on analyzing Petros Stock price patterns and their correlations with different microeconomic environments and drivers.
Petros Pharmaceuticals Predictive Forecast Models
Petros Pharmaceuticals' time-series forecasting models is one of many Petros Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Petros Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Petros Pharmaceuticals
Checking the ongoing alerts about Petros Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Petros Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Petros Pharmaceuticals had very high historical volatility over the last 90 days | |
| Petros Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Petros Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 5.82 M. Net Loss for the year was (8.16 M) with profit before overhead, payroll, taxes, and interest of 6.21 M. | |
| Petros Pharmaceuticals currently holds about 13.3 M in cash with (7.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.64, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from MacroaxisInsider: Acquisition by Gesek Andrew of tradable shares of Petros Pharmaceuticals at 3.99 subject to Rule 16b-3 |
Check out Petros Pharmaceuticals Backtesting, Petros Pharmaceuticals Valuation, Petros Pharmaceuticals Correlation, Petros Pharmaceuticals Hype Analysis, Petros Pharmaceuticals Volatility, Petros Pharmaceuticals History as well as Petros Pharmaceuticals Performance. For more detail on how to invest in Petros Stock please use our How to Invest in Petros Pharmaceuticals guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Petros Pharmaceuticals. If investors know Petros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Petros Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.80) | Revenue Per Share 0.99 | Quarterly Revenue Growth (0.29) | Return On Assets (0.31) | Return On Equity (0.64) |
The market value of Petros Pharmaceuticals is measured differently than its book value, which is the value of Petros that is recorded on the company's balance sheet. Investors also form their own opinion of Petros Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Petros Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Petros Pharmaceuticals' market value can be influenced by many factors that don't directly affect Petros Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Petros Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Petros Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Petros Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.